GIP
SPPI

Granite Investment Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Granite Investment Partners’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-64,690
Closed -$910K – 317
2017
Q3 		$910K Sell
64,690
-32,333
-33% -$293K 0.06% 223
2017
Q2 		$723K Sell
97,023
-104,198
-52% -$681K 0.05% 259
2017
Q1 		$1.31M Sell
201,221
-991
-0.5% -$5.54K 0.09% 201
2016
Q4 		$896K Buy
202,212
+81,870
+68% +$343K 0.07% 241
2016
Q3 		$562K Buy
+120,342
New +$713K 0.04% 269

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Granite Investment Partners's SPPI Position: Q4 2017 in Review

Granite Investment Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 64,690 shares — an estimated $910K sold.

Granite Investment Partners first reported a position in SPPI in Q3 2016 and held it in 5 quarters. The position peaked at $1.31M in Q1 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

  • Granite Investment Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Granite Investment Partners sold 64,690 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $910K.
  • Granite Investment Partners first reported a position in Spectrum Pharmaceuticals Inc in Q3 2016 and held it in 5 quarters.
  • Granite Investment Partners's Spectrum Pharmaceuticals Inc position peaked at $1.31M in Q1 2017.
  • 157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Granite Investment Partners's 13F filing for Q4 2017, filed 1 Feb 2018.